Imbert T F
Division of Medicinal Chemistry, Centre de Recherche Pierre Fabre, Castres, France.
Biochimie. 1998 Mar;80(3):207-22. doi: 10.1016/s0300-9084(98)80004-7.
This review deals with the historical discovery of particularly important lignan derivatives used in cancer chemotherapy. From isolation of the naturally occurring podophyllotoxin, an inhibitor of microtubule assembly, to hemisynthesis of the clinically important anticancer drugs etoposide and teniposide, it will be demonstrated how the activities and the ability of this class of compounds to inhibit topoisomerase II were discovered by different research teams. By virtue of these discoveries, new hemisynthetic derivatives, with different mechanisms of action, are bringing improvements in the ability to treat cancer.
本综述涉及在癌症化疗中使用的特别重要的木脂素衍生物的历史发现。从天然存在的微管组装抑制剂鬼臼毒素的分离,到临床上重要的抗癌药物依托泊苷和替尼泊苷的半合成,将展示不同研究团队是如何发现这类化合物抑制拓扑异构酶II的活性和能力的。凭借这些发现,具有不同作用机制的新型半合成衍生物正在提高治疗癌症的能力。